Access cutting-edge cancer treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access cancer specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
The goal of this clinical trial is to evaluate FMC-376 in participants with advanced solid tumors with KRAS G12C mutations. This clinical trial will be conducted in 3 parts: Phase 1A (Dose Escalation), Phase 1B (Dose Expansion), and Phase 2 (Cohort Expansion). Multiple dose levels in participants with advanced solid tumors will be evaluated.
Sponsor: Frontier Medicines Corporation
Check if you qualify for this cancer clinical trial in Detroit, MI
If you're searching for cancer treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.